(Q37836489)

24 August 2017

1 reference

title

How to improve the immunogenicity of chemotherapy and radiotherapy (English)

1 reference

Adaptive radiation therapy

24 August 2017

main subject

0 references

1 reference

7

Laurence Zitvogel

0 references

Guido Kroemer

6

Guido Kroemer

0 references

Oliver Kepp

5

Oliver Kepp

0 references

Laetitia Aymeric

3

Laetitia Aymeric

0 references

Clara Locher

4

Clara Locher

0 references

Yuting Ma

1

Yuting Ma

1 reference

24 August 2017

2

Rosa Conforti

1 reference

24 August 2017

language of work or name

1 reference

1 March 2011

1 reference

Cancer and Metastasis Reviews

24 August 2017

published in

1 reference

24 August 2017

volume

30

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

71-82

1 reference

https://scigraph.springernature.com/pub.10.1007/s10555-011-9283-2

24 August 2017

exact match

0 references

cites work

Combinatorial cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Radiation induces an antitumour immune response to mouse melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Chemotherapy and radiotherapy: cryptic anticancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Mincle is an ITAM-coupled activating receptor that senses damaged cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Hsp60-mediated T cell stimulation is independent of TLR4 and IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

The sterile inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Microparticles as mediators of cellular cross-talk in inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Migration to apoptotic "find-me" signals is mediated via the phagocyte receptor G2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Ecto-calreticulin in immunogenic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Heat shock proteins: essential proteins for apoptosis regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Towards a better way to die with chemotherapy: role of heat shock protein exposure on dying tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Molecular characteristics of immunogenic cancer cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Heat shock protein 90 mediates efficient antigen cross presentation through the scavenger receptor expressed by endothelial cells-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Role of chaperones and FcgammaR in immunogenic death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Phagocytosis and clearance of apoptotic cells is mediated by MER.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Sensing necrosis with Mincle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Differential antigen processing by dendritic cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Targeting the stroma by T cells to limit tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Bystander elimination of antigen loss variants in established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Human gamma delta T cells: a lymphoid lineage cell capable of professional phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Cancer immunotherapy by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Paradoxical roles of the immune system during cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Natural killer and gammadelta T cells in haematological malignancies: enhancing the immune effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Immune infiltration in human tumors: a prognostic factor that should not be ignored

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Polarized immune responses differentially regulate cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Immune cells as mediators of solid tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Derangement of immune responses by myeloid suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Differences in tumor regulatory T-cell localization and activation status impact patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Therapeutic targeting of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Mechanisms of drug resistance in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Clusterin and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

The redox protein HMGB1 regulates cell death and survival in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Endoplasmic reticulum stress and autophagy as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Targeting myeloid leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

The difficulty of targeting cancer stem cell niches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Adjuvants for cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Building on dendritic cell subsets to improve cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Taming cancer by inducing immunity via dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Combination immunotherapy with radiation and CpG-based tumor vaccination for the eradication of radio- and immuno-resistant lung carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9283-2

10.1007/S10555-011-9283-2

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference